Several groups of drugs are used in monotherapy or in polytherapy of diabetes. It includes insulin and insulin analogues, insulin secretagogues, insulin sensitizers, and drugs with different mechanisms of action.

There are higher chances that antidiabetic medication may modify the cancer risk in diabetic patients. This exclusive KOL Interview shares an opinion about how cancer risk can be managed in diabetes patients.